Showing results (2341-2350 of 8,098) with videos related to
Sort By:
Pageof 810
Current Medicinal Chemistry|December 31, 2013
CD147: a novel modulator of inflammatory and immune disordersX Zhu, Z Song, S Zhang, et al.Current Medicinal Chemistry|December 31, 2013
Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic eventsMia-Jeanne van Rooy, E PretoriusCurrent Medicinal Chemistry|December 31, 2013
Functional genomics in zebrafish as a tool to identify novel antiarrhythmic targetsA Pott, W Rottbauer, S JustCurrent Medicinal Chemistry|December 20, 2013
Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognitionI A Schepetkin, A I Khlebnikov, M P Giovannoni, et al.Current Medicinal Chemistry|December 20, 2013
Development of HIV-1 fusion inhibitors targeting gp41K Lu, M R Asyifah, F Shao, et al.Current Medicinal Chemistry|November 5, 2013
Synthesis and antiproliferative activity of substituted 3[2-(1H-indol-3-yl)- 1,3-thiazol-4-yl]-1H-pyrrolo[3,2-b]pyridines, marine alkaloid nortopsentin analoguesA Carbone, M Pennati, P Barraja, et al.Current Medicinal Chemistry|January 6, 2022
Host Microbiomes in Tumor Precision Medicine: How far are we?Federica D'Amico, Monica Barone, Teresa Tavella, et al.Current Medicinal Chemistry|March 15, 2021
Inhibiting the "Undruggable" RAS/Farnesyltransferase (FTase) Cancer Target by Manumycin-related Natural ProductsLeandro Rocha Silva, Edeildo Ferreira da Silva-JúniorCurrent Medicinal Chemistry|March 22, 2021
Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target PerspectiveVishal Kumar, Sanjeev Dhawan, Pankaj Sanjay Girase, et al.Current Medicinal Chemistry|March 22, 2021
Methicillin-Resistant Staphylococcus Aureus (MRSA) Pyruvate Kinase (PK) Inhibitors and their Antimicrobial ActivitiesJingjing Jia, Yang Luo, Xue Zhong, et al.Pageof 810